Delivery Order SPE2DE21D0017-SPE2D625F2ZG8
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostic equipment and testing supplies, has been awarded a delivery order valued at $6,720.00 for ID NOW Strep tests by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 30, 2025, with an ultimate completion date of August 6, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, indicating...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a $14,448 fixed-price delivery order with economic price adjustment for ID NOW Strep diagnostic tests by the Defense Logistics Agency Medical Supply Chain. The award, issued on October 27, 2025, with an ultimate completion date of November 3, 2025, represents a delivery order under an existing indefinite delivery vehicle contract. The place of performance is located in Lockhart, Florida. This contract...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order valued at $10,416.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 15, 2025, for ID NOW Strep diagnostic tests. The contract, awarded without set-aside designation under full and open competition, is scheduled for completion by July 22, 2025, and will be performed in Lockhart, Florida. This delivery order represents a continuation of Abbott's established role...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a fixed-price delivery order valued at $6,720.00 from the Defense Logistics Agency (DLA) Medical Supply Chain on August 22, 2025, for ID NOW Strep diagnostic testing supplies. The contract, which is not set-aside and awarded under open competition, is scheduled for completion by August 29, 2025, and will be performed in Lockhart, Florida. This delivery order represents a continuation of the company's...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order valued at $3,360.00 by the Defense Logistics Agency Medical Supply Chain on September 3, 2025. The delivery order, which carries an ultimate completion date of September 10, 2025, is for ID NOW Strep A Qualitative Detection Microbiology test kits. The contract was awarded without set-aside designation, indicating open competition. Performance will be completed in Lockhart,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostic equipment and testing supplies, was awarded a $2,688 fixed-price delivery order with economic price adjustment on June 16, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a Kit ID NOW Strep A2 Qual Detect Microbial Test, is scheduled for completion by June 20, 2025, and will be performed in Lockhart, Florida. This delivery order was awarded without a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order valued at $69,600 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The contract, which runs through August 28, 2025, covers ID NOW flu testing supplies and is classified as a Delivery Order with economic price adjustment provisions. The award was made through open competition with no set-aside designation, and performance will occur in Lockhart, Florida....
- This is a fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract, valued at $12,768.00, is for the delivery of ID NOW STREP rapid diagnostic tests. The contract has a period of performance through June 13, 2025 and does not have a set-aside designation. Abbott Rapid DX North America LLC is a key supplier of medical diagnostic equipment and testing supplies to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the provision of ID NOW STREP diagnostic tests. The contract is a fixed-price delivery order with economic price adjustment, with a ceiling value of $2,112.00 and a completion date of October 29, 2024. The contract is not set aside for any specific business category. Abbott Rapid DX North America LLC is a critical vendor...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F2ZG8Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostic equipment and testing supplies, has been awarded a delivery order valued at $5,040.00 by the Defense Logistics Agency Medical Supply Chain for ID NOW Strep tests. The contract, awarded on June 18, 2025, with an ultimate completion date of June 26, 2025, utilizes fixed-price pricing with economic price adjustment and was awarded without a set-aside designation, indicating open competition. Performance will be executed in Lockhart, Florida. This delivery order represents a continuation of Abbott Rapid DX North America LLC's established role as a critical federal supplier of point-of-care diagnostic products, particularly to Department of Defense and Department of Veterans Affairs healthcare facilities. The company maintains multiple significant Indefinite Delivery Vehicles with various Veterans Integrated Service Networks and holds GSA Schedule contracts for in vitro diagnostics and testing supplies. This award aligns with the company's primary contract portfolio, which has historically focused on supplying rapid diagnostic testing capabilities to support federal healthcare and defense initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 6/18/25 |